Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOECONOMY | - | Spring Semester | 2+0 | 2 | 3 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Elective |
| Course Coordinator | Assist.Prof. İPEK EROĞLU |
| Name of Lecturer(s) | Assist.Prof. İPEK EROĞLU |
| Assistant(s) | |
| Aim | Teach the students the concepts and types of costs used in pharmacoeconomic assessments. |
| Course Content | This course contains; Introduction: Pharmacoeconomics Definition and importance,Pharmacoeconomic Studies,Costing Terms, measuring and estimating costs,Cost Minimization Analysis (CMA),Cost effectiveness Analysis (CEA),article review: cost effectiveness analysis,Cost Utility Analysis (CUA),article review: cost utility analysis,Cost Benefit analysis (CBA),article review: cost benefit analaysis,Pricing of pharmaceuticals and reimbursement,Reference pricing,Risk sharing agreements,Pharmaceutical sector in Turkey. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1.Able to explain the concepts related to pharmacoeconomics and the concept of pharmacoeconomics. | 10, 16, 9 | A |
| 1.1.Defines the concept of cost and summarises the methods of cost calculation and estimation. | 10, 16, 9 | A |
| 1.2.Able to explain drug pricing and reimbursement systems. | 10, 16, 9 | A |
| 2.Able to interpret the studies related to pharmacoeconomic analysis methods. | 10, 16, 9 | A |
| Teaching Methods: | 10: Discussion Method, 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction: Pharmacoeconomics Definition and importance | 1 |
| 2 | Pharmacoeconomic Studies | 1 |
| 3 | Costing Terms, measuring and estimating costs | 1 |
| 4 | Cost Minimization Analysis (CMA) | 1 |
| 5 | Cost effectiveness Analysis (CEA) | 1 |
| 6 | article review: cost effectiveness analysis | 1 |
| 7 | Cost Utility Analysis (CUA) | 1 |
| 8 | article review: cost utility analysis | 1 |
| 9 | Cost Benefit analysis (CBA) | 1 |
| 10 | article review: cost benefit analaysis | 1 |
| 11 | Pricing of pharmaceuticals and reimbursement | 1 |
| 12 | Reference pricing | 1 |
| 13 | Risk sharing agreements | 1 |
| 14 | Pharmaceutical sector in Turkey | 1 |
| Resources |
| 1. Bootman, J. L, Townsend R. J., McGhan W. F. "Farmakoekonominin Prensipleri", Koçkaya, G (Çev. Ed.), 2012 |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | ||||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | ||||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | ||||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | ||||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | ||||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | ||||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | ||||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | ||||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | ||||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | ||||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 14 | 2 | 28 | |||
| Guided Problem Solving | 0 | 0 | 0 | |||
| Resolution of Homework Problems and Submission as a Report | 3 | 5 | 15 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 1 | 5 | 5 | |||
| Quiz | 1 | 1 | 1 | |||
| Midterm Exam | 1 | 10 | 10 | |||
| General Exam | 1 | 20 | 20 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 79 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(79/30) | 3 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOECONOMY | - | Spring Semester | 2+0 | 2 | 3 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Elective |
| Course Coordinator | Assist.Prof. İPEK EROĞLU |
| Name of Lecturer(s) | Assist.Prof. İPEK EROĞLU |
| Assistant(s) | |
| Aim | Teach the students the concepts and types of costs used in pharmacoeconomic assessments. |
| Course Content | This course contains; Introduction: Pharmacoeconomics Definition and importance,Pharmacoeconomic Studies,Costing Terms, measuring and estimating costs,Cost Minimization Analysis (CMA),Cost effectiveness Analysis (CEA),article review: cost effectiveness analysis,Cost Utility Analysis (CUA),article review: cost utility analysis,Cost Benefit analysis (CBA),article review: cost benefit analaysis,Pricing of pharmaceuticals and reimbursement,Reference pricing,Risk sharing agreements,Pharmaceutical sector in Turkey. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1.Able to explain the concepts related to pharmacoeconomics and the concept of pharmacoeconomics. | 10, 16, 9 | A |
| 1.1.Defines the concept of cost and summarises the methods of cost calculation and estimation. | 10, 16, 9 | A |
| 1.2.Able to explain drug pricing and reimbursement systems. | 10, 16, 9 | A |
| 2.Able to interpret the studies related to pharmacoeconomic analysis methods. | 10, 16, 9 | A |
| Teaching Methods: | 10: Discussion Method, 16: Question - Answer Technique, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction: Pharmacoeconomics Definition and importance | 1 |
| 2 | Pharmacoeconomic Studies | 1 |
| 3 | Costing Terms, measuring and estimating costs | 1 |
| 4 | Cost Minimization Analysis (CMA) | 1 |
| 5 | Cost effectiveness Analysis (CEA) | 1 |
| 6 | article review: cost effectiveness analysis | 1 |
| 7 | Cost Utility Analysis (CUA) | 1 |
| 8 | article review: cost utility analysis | 1 |
| 9 | Cost Benefit analysis (CBA) | 1 |
| 10 | article review: cost benefit analaysis | 1 |
| 11 | Pricing of pharmaceuticals and reimbursement | 1 |
| 12 | Reference pricing | 1 |
| 13 | Risk sharing agreements | 1 |
| 14 | Pharmaceutical sector in Turkey | 1 |
| Resources |
| 1. Bootman, J. L, Townsend R. J., McGhan W. F. "Farmakoekonominin Prensipleri", Koçkaya, G (Çev. Ed.), 2012 |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | PQ-1. Skilfully use information technology to access, follow, evaluate and apply current knowledge in the field of Pharmaceutical Sciences. | X | |||||
| 2 | PQ-2. Have advanced knowledge in APIs and DPs. | ||||||
| 3 | PQ-3. Collaborate with the experts for collection, interpretation, application and declaration of data in Pharmaceutical Sciences field. | X | |||||
| 4 | PQ-4. Provide best patient counseling services and medication therapy management using his/her knowledge and pharmaceutical information systems to improve the quality of life and safety of patient. | X | |||||
| 5 | PQ-5. Capable of organizing and administering a drugstore as per responsibilities prescribed under the Pharmacy Law, using skills, knowledge and advanced technology systems. | X | |||||
| 6 | PQ-6. Skilfully use computer programs and advanced technology related to the Pharmaceutical Sciences. | ||||||
| 7 | PQ-7. Provide solutions to the professional issues using scientific knowledge and data. | ||||||
| 8 | PQ-8. Perform identification, quality control and standardization of the drug products. | ||||||
| 9 | PQ-9. Prepare and implement developmental plans for his/her subordinates, frequently evaluate their progress and make necessary adjustments. | X | |||||
| 10 | PQ-10. Capable of conducting independent studies with his/her advanced knowledge in pharmaceutical sciences, takes responsibilities in professional organizations and efficiently collaborates with the members of his/her own organization as well as other organizations. | X | |||||
| 11 | PQ-11. Clearly show signs of adoption of life-long learning and openness to further development. | X | |||||
| 12 | PQ-12. Critically evaluate their knowledge in pharmaceutical sciences. | ||||||
| 13 | PQ-13. Closely follow and evaluate the national and international professional developments. | X | |||||
| 14 | PQ-14. Record and document all professional activities and applications. | X | |||||
| 15 | PQ-15. Communicate all necessary information about medicines to patient, medical personnel and public. | ||||||
| 16 | PQ-16. Proficient in English to communicate and follow current knowledge in pharmaceutical sciences. | ||||||
| 17 | PQ-17. Inform officials and organizations about the issues with the quality assurance of pharmaceutical products. | ||||||
| 18 | PQ-18. Actively involve in the preparation of APIs, every stage of the formulation and production of DPs. | X | |||||
| 19 | PQ-19. Knowledgable in the regulatory rules of new drug application, data protection and patent issues and understand their interrelationship. | X | |||||
| 20 | PQ-20. Have awareness of his/her duties, rights and responsibilities and act based on Pharmacy Law and high professional ethical standards. | ||||||
| 21 | PQ-21. Familiar with and actively pursue the personal and public health, environmental, and work safety issues. | ||||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |